This difference in results stems from key disparities in inclusion criteria and data extraction between the two studies: (1) HR of a subgroup analysis reported by Mulder et al. for AF patients with NT pro-BNP more than 1003 pg/mL was taken as a surrogate for heart failure by Ouyang et al. while we did not make such assumptions. This evidence concerns the gene NPPB and atrial fibrillation.